{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:29:11Z","timestamp":1792682951904,"version":"4.5.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009055","name":"Center for International Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009055","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The duration of protection after a single dose of yellow fever vaccine is a matter of debate. To summarize the current knowledge, we performed a systematic literature review and meta-analysis. Studies on the duration of protection after 1 and \u22652 vaccine doses were reviewed. Data were stratified by time since vaccination. In our meta-analysis, we used random-effects models. We identified 36 studies from 20 countries, comprising more than 17 000 participants aged 6 months to 85 years. Among healthy adults and children, pooled seroprotection rates after single vaccination dose were close to 100% by 3 months and remained high in adults for 5 to 10 years. In children vaccinated before age 2 years, the seroprotection rate was 52% within 5 years after primary vaccination. For immunodeficient persons, data indicate relevant waning. The extent of waning of seroprotection after yellow fever vaccination depends on age and immune status at primary vaccination.<\/jats:p>","DOI":"10.1093\/cid\/ciac580","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:38:58Z","timestamp":1658306338000},"page":"2266-2274","source":"Crossref","is-referenced-by-count":37,"title":["Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-0814","authenticated-orcid":false,"given":"Kerstin","family":"Kling","sequence":"first","affiliation":[{"name":"Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Domingo","sequence":"additional","affiliation":[{"name":"Center for International Health Protection, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Mikrobiologisches Institut \u2013 Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich Alexander Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen , Erlangen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Duffy","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd , York , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harder","sequence":"additional","affiliation":[{"name":"Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Howick","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd , York , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd , York , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McDermott","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd , York , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Wilder-Smith","sequence":"additional","affiliation":[{"name":"Heidelberg Institute of Global Health, University of Heidelberg , Heidelberg , Germany"},{"name":"Institute of Social and Preventive Medicine, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wolff","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd , York , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"2022121911383532500_ciac580-B1","author":"WHO"},{"key":"2022121911383532500_ciac580-B2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"2022121911383532500_ciac580-B3","doi-asserted-by":"crossref","first-page":"taz040","DOI":"10.1093\/jtm\/taz040","article-title":"Severe yellow fever in Brazil: clinical characteristics and management","volume":"26","author":"Ho","year":"2019","journal-title":"J Travel Med"},{"key":"2022121911383532500_ciac580-B4","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper \u2013 June 2013","volume":"88","author":"WHO","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"2022121911383532500_ciac580-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: current epidemiology and vaccination strategies","volume":"6","author":"Chen","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"2022121911383532500_ciac580-B6","doi-asserted-by":"crossref","first-page":"e0006538","DOI":"10.1371\/journal.pntd.0006538","article-title":"Persistence of yellow fever virus outside the Amazon basin, causing epidemics in southeast Brazil, from 2016 to 2018","volume":"12","author":"Rezende","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2022121911383532500_ciac580-B7","doi-asserted-by":"crossref","first-page":"e8601","DOI":"10.7717\/peerj.8601","article-title":"Modelling the effective reproduction number of vector-borne diseases: the yellow fever outbreak in Luanda, Angola 2015-2016 as an example","volume":"8","author":"Zhao","year":"2020","journal-title":"PeerJ"},{"key":"2022121911383532500_ciac580-B8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/14760584.2016.1198259","article-title":"Questions regarding the safety and duration of immunity following live yellow fever vaccination","volume":"15","author":"Amanna","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"2022121911383532500_ciac580-B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/21645515.2015.1082693","article-title":"Booster dose after 10 years is recommended following 17DD-YF primary vaccination","volume":"12","author":"Campi-Azevedo","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2022121911383532500_ciac580-B10","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay130","article-title":"Ten yearly yellow fever booster vaccinations may still be justified","volume":"25","author":"Plotkin","year":"2018","journal-title":"J Travel Med"},{"key":"2022121911383532500_ciac580-B11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-020-0205-6","article-title":"Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection","volume":"5","author":"Staples","year":"2020","journal-title":"npj Vaccines"},{"key":"2022121911383532500_ciac580-B12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/0074-02760170347","article-title":"Single shot of 17D vaccine may not confer life-long protection against yellow fever","volume":"113","author":"Vasconcelos","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2022121911383532500_ciac580-B13","author":"Centre for Reviews and Dissemination"},{"key":"2022121911383532500_ciac580-B14","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019)","author":"Higgins","year":"2019"},{"key":"2022121911383532500_ciac580-B15","author":"PRISMA Group"},{"key":"2022121911383532500_ciac580-B16","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2022121911383532500_ciac580-B17","author":"Joanna Briggs Institute"},{"key":"2022121911383532500_ciac580-B18","author":"WHO"},{"key":"2022121911383532500_ciac580-B19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2022121911383532500_ciac580-B20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"key":"2022121911383532500_ciac580-B21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"key":"2022121911383532500_ciac580-B22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/0074-02760150176","article-title":"A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213\/77 in children nine-23 months old","volume":"110","author":"Collaborative Group for Studies of Yellow Fever Vaccine","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2022121911383532500_ciac580-B23","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.vaccine.2020.03.014","article-title":"Immunogenicity and safety of the RTS, S\/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: a phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial","volume":"38","author":"Asante","year":"2020","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2022121911383532500_ciac580-B25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2334-14-391","article-title":"Subdoses of 17DD yellow fever vaccine elicit equivalent virological\/immunological kinetics timeline","volume":"14","author":"Campi-Azevedo","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2022121911383532500_ciac580-B26","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"1","author":"Chan","year":"2016","journal-title":"Nat Microbiol"},{"key":"2022121911383532500_ciac580-B27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0264-410X(95)80020-E","article-title":"Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines","volume":"13","author":"Coursaget","year":"1995","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2012.12-0179","article-title":"A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity","volume":"88","author":"Edupuganti","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2022121911383532500_ciac580-B29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"key":"2022121911383532500_ciac580-B30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(20)32520-4","article-title":"Immunogenicity and safety of fractional doses of yellow fever vaccines: A randomised, double-blind, non-inferiority trial","volume":"397","author":"Juan-Giner","year":"2021","journal-title":"Lancet"},{"key":"2022121911383532500_ciac580-B31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"2022121911383532500_ciac580-B32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/INF.0000000000001250","article-title":"Immunogenicity and safety of yellow fever vaccine (Stamaril) when administered concomitantly with a tetravalent Dengue vaccine candidate in healthy toddlers at 12-13 months of age in Colombia and Peru: a randomized trial","volume":"35","author":"Lopez","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2022121911383532500_ciac580-B33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"2022121911383532500_ciac580-B34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4161\/hv.6.11.12854","article-title":"Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum Vaccin"},{"key":"2022121911383532500_ciac580-B35","first-page":"1056","article-title":"Study to evaluate the safety and immunogenicity of travel vaccines when administered concomitantly with meningococcal ACWY conjugate vaccine in healthy adults","volume":"11","author":"Novartis Vaccines and Diagnostics S.r.l","year":"2011","journal-title":"ICTRP"},{"key":"2022121911383532500_ciac580-B36","first-page":"1056","article-title":"Antibody response to 17D yellow fever vaccine in Ghanaian infants","volume":"79","author":"Osei-Kwasi","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2022121911383532500_ciac580-B37","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS One"},{"key":"2022121911383532500_ciac580-B38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano","year":"1999","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B39","doi-asserted-by":"crossref","first-page":"e0005219","DOI":"10.1371\/journal.pntd.0005219","article-title":"CD4\/CD8 Ratio and KT ratio predict yellow fever vaccine immunogenicity in HIV-infected patients","volume":"10","author":"Avelino-Silva","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2022121911383532500_ciac580-B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/QAI.0000000000000845","article-title":"CD4\/CD8 Ratio predicts yellow fever vaccine-induced antibody titers in virologically suppressed HIV-infected patients","volume":"71","author":"Avelino-Silva","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022121911383532500_ciac580-B41","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2019.12.042","article-title":"Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals","volume":"38","author":"Burkhard","year":"2020","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B42","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/j.vaccine.2019.05.048","article-title":"Duration of immunity in recipients of two doses of 17DD yellow fever vaccine","volume":"37","author":"Collaborative group for studies on yellow fever vaccines","year":"2019","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B43","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3201\/eid2508.181432","article-title":"17DD Yellow fever revaccination and heightened long-term immunity in populations of disease-endemic areas, Brazil","volume":"25","author":"Campi-Azevedo","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2022121911383532500_ciac580-B44","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/QAD.0000000000001963","article-title":"Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients","volume":"32","author":"de Verdiere","year":"2018","journal-title":"AIDS"},{"key":"2022121911383532500_ciac580-B45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/acr.22021","article-title":"Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study","volume":"65","author":"Kerneis","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022121911383532500_ciac580-B46","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.vaccine.2015.03.069","article-title":"Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?","volume":"33","author":"Michel","year":"2015","journal-title":"Vaccine"},{"key":"2022121911383532500_ciac580-B47","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006454-199712000-00015","article-title":"Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1","volume":"16","author":"Sibailly","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2022121911383532500_ciac580-B48","doi-asserted-by":"crossref","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS One"},{"key":"2022121911383532500_ciac580-B49","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fimmu.2020.01382","article-title":"Planned yellow fever primary vaccination is safe and immunogenic in patients with autoimmune diseases: a prospective non-interventional study","volume":"11","author":"Valim","year":"2020","journal-title":"Front Immunol"},{"key":"2022121911383532500_ciac580-B50","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3389\/fimmu.2019.02192","article-title":"Short-lived immunity after 17DD yellow fever single dose indicates that booster vaccination may be required to guarantee protective immunity in children","volume":"10","author":"Campi-Azevedo","year":"2019","journal-title":"Front Immunol"},{"key":"2022121911383532500_ciac580-B51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1473-3099(19)30323-8","article-title":"Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study","volume":"19","author":"Domingo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022121911383532500_ciac580-B52","doi-asserted-by":"crossref","first-page":"577751","DOI":"10.3389\/fimmu.2020.577751","article-title":"Serological protection 5-6 years post vaccination against yellow fever in African infants vaccinated in routine programmes","volume":"11","author":"Idoko","year":"2020","journal-title":"Front Immunol"},{"key":"2022121911383532500_ciac580-B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.12.001","article-title":"Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa","volume":"162","author":"Jia","year":"2019","journal-title":"Antiviral Res"},{"key":"2022121911383532500_ciac580-B54","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/infdis\/jiz374","article-title":"Persistence of neutralizing antibody responses among yellow fever virus 17D vaccinees living in a nonendemic setting","volume":"221","author":"Kareko","year":"2020","journal-title":"J Infect Dis"},{"key":"2022121911383532500_ciac580-B55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/cix960","article-title":"Long-term immune response to yellow fever vaccination in human immunodeficiency virus (HIV)-infected individuals depends on HIV RNA suppression status: implications for vaccination schedule","volume":"66","author":"Veit","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2022121911383532500_ciac580-B56","doi-asserted-by":"crossref","first-page":"taab126","DOI":"10.1093\/jtm\/taab126","article-title":"Long-term immunity after a single yellow fever vaccination in travelers vaccinated at 60 years or older: a 10-year follow-up study","volume":"28","author":"Rosenstein","year":"2021","journal-title":"J Travel Med"},{"key":"2022121911383532500_ciac580-B57","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2022121911383532500_ciac580-B58","doi-asserted-by":"crossref","first-page":"tay134","DOI":"10.1093\/jtm\/tay134","article-title":"Waning immunity after single-dose yellow fever vaccination: who needs a second shot?","volume":"26","author":"Visser","year":"2019","journal-title":"J Travel Med"},{"key":"2022121911383532500_ciac580-B59","author":"Centres for Disease Control and Prevention"},{"key":"2022121911383532500_ciac580-B60","author":"WHO"},{"key":"2022121911383532500_ciac580-B61","doi-asserted-by":"crossref","first-page":"e00008520","DOI":"10.1590\/0102-311x00008520","article-title":"Vaccine failures: assessing yellow fever, measles, varicella, and mumps vaccines","volume":"36","author":"Petraglia","year":"2020","journal-title":"Cadernos de saude publica"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac580\/45322114\/ciac580.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/12\/2266\/48162799\/ciac580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/12\/2266\/48162799\/ciac580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T06:58:16Z","timestamp":1671433096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/12\/2266\/6646957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,7,20]]},"published-print":{"date-parts":[[2022,12,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac580","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742243709.793594413","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.21.22276699","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,15]]},"published":{"date-parts":[[2022,7,20]]}}}